CTNNB1 and hepatoblastoma: We provide promising evidence for the utility of quantitative CTNNB1 ctDNA detection in hepatoblastoma for dynamic tumor burden and treatment response monitoring, compared with the current clinical indicators and biomarkers for this disease.